Cookies on this site

A major new study led by the University of Oxford and global partners has exposed significant global blind spots in genomic surveillance of antimicrobial resistance (AMR), warning that large parts of the world lack the data needed to track and respond to emerging threats.

Group of people

Published in PLOS Global Public Health during World AMR Awareness Week, the analysis shows that 89 countries have no publicly available genomic data for key drug-resistant pathogens, and 146 have not been able to contribute any data since 2020.

AMR already causes more than a million deaths each year and makes routine medical care increasingly challenging. The authors stress that without stronger and more equitable global surveillance systems, resistant infections will continue to undermine modern medicine.

The study uses data drawn from amr.watch, a freely accessible platform developed by Oxford’s Centre for Genomic Pathogen Surveillance (CGPS) at the Pandemic Sciences Institute, Nuffield Department of Medicine. Despite more than 620,000 genomes being available globally, nearly 90% come from high-income countries, with the USA and UK alone contributing over 65%. Barriers such as limited laboratory capacity, high costs, and data infrastructure gaps continue to hinder sequencing efforts in many low- and middle-income regions.

 

Read the full story on the Nuffield Department of Medicine website.

Similar stories

Research shows for the first time that standard non-contrast CT scans can be analysed by AI to reveal hidden coronary inflammation

Researchers from 27 institutions across UK, USA, Europe and Australia, led by a team at the University of Oxford, have demonstrated how an AI technology can measure inflammation in the heart’s arteries using low-radiation CT heart scans typically used to measure calcium score.

Five European Research Council (ERC) Synergy Grants awarded to Oxford researchers for ambitious new collaborations

Five Oxford University academics are to co-lead ambitious new research projects backed by European Research Council (ERC) Synergy Grants, part of the EU’s Horizon Europe research and innovation programme. Synergy Grants support groups of two to four outstanding researchers who combine complementary expertise and resources to tackle ambitious scientific challenges that could not be addressed by individual teams alone.

Professor Ole Jensen (Department of Experimental Psychology) and colleagues received €13.6 million to discover when the brain is ready for language and social understanding

The team will use new wearable brain sensors to track cognitive development from before birth to eight years of age.

New 'molecular glue' helps break down antibiotic resistance enzymes in E. coli

Oxford University scientists have discovered a new approach to tackle antimicrobial resistance (AMR), using 'molecular glues' to encourage bacteria to destroy their own resistance-causing enzymes. The study has been published in Angewandte Chemie International Edition.

Stronger immune system may help protect against prostate cancer

Higher levels of proteins involved in activating and coordinating the immune system were associated with a lower risk of developing prostate cancer, in a new study led by researchers at the Nuffield Department of Population Health.

The Nuffield Department of Women's & Reproductive Health has published its Biennial Report 2024–26

The Biennial Report 2024–26 highlights two years of research excellence, innovation, collaboration and growth.